Scholarlink

Background <p>Triple-negative breast cancer (TNBC) continues to significantly threaten human health despite using multiple advanced therapies. The development of simple and effective pharmacologic agents, combined with various available treatments, has the potential to achieve unexpected efficacy. The aim of this study was to develop a gambogic amide coated nanomicelles for the multi-synergistic treatment of triple-negative breast cancer. This study developed PLGA-PEG/GA (PPG) nanoparticles by combining gambogic amide (GA) with polyethylene glycol-grafted poly(lactic-<i>co</i>-glycolic) acid copolymer (PLGA-PEG) for use in synergistic tumor therapies.</p> Results <p>Intravenous injection of PPG disrupts tumor vasculature and forms blood clots, which in turn mediates photothermal therapy and promotes oxygen release to enhance sensitivity to radiotherapy. More importantly, in addition to starvation therapy that disrupts tumor blood supply, PPG promotes tumor immunogenic death and activates the cGAS–STING pathway, triggering effective systemic anti-tumor immunity. When combined with PD-L1, PPG therapy reduces tumor recurrence.</p> Conclusion <p>Overall, PPG can synergize with a variety of therapies to activate systemic anti-tumor effects while treating tumors locally.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Tumor vascular disruption and cGAS–STING activation by gambogic amide-loaded nanomicelles for multiple synergistic treatment of triple-negative breast cancer

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年8月26日

查看全文
  • Zhengwei Gui,
  • Lu Zhao,
  • Shiyang Liu,
  • Lin Zhang

摘要

Background

Triple-negative breast cancer (TNBC) continues to significantly threaten human health despite using multiple advanced therapies. The development of simple and effective pharmacologic agents, combined with various available treatments, has the potential to achieve unexpected efficacy. The aim of this study was to develop a gambogic amide coated nanomicelles for the multi-synergistic treatment of triple-negative breast cancer. This study developed PLGA-PEG/GA (PPG) nanoparticles by combining gambogic amide (GA) with polyethylene glycol-grafted poly(lactic-co-glycolic) acid copolymer (PLGA-PEG) for use in synergistic tumor therapies.

Results

Intravenous injection of PPG disrupts tumor vasculature and forms blood clots, which in turn mediates photothermal therapy and promotes oxygen release to enhance sensitivity to radiotherapy. More importantly, in addition to starvation therapy that disrupts tumor blood supply, PPG promotes tumor immunogenic death and activates the cGAS–STING pathway, triggering effective systemic anti-tumor immunity. When combined with PD-L1, PPG therapy reduces tumor recurrence.

Conclusion

Overall, PPG can synergize with a variety of therapies to activate systemic anti-tumor effects while treating tumors locally.

Graphical Abstract